Release Date: 11/11/13 17:23 Summary: Ceasing to be a substantial holder from MQG Price Sensitive: No Download Document 233.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%